The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback